Radi E, Formichi P, Battisti C, Federico A
Beginning at 2.5 mg may reduce side effects such as nausea or stomach discomfort before increasing the dose
Actual timing depends on clinician availability, state requirements, pharmacy queue, and shipping distance, so treat these as typical editorial estimates rather than guarantees
This number can fluctuate significantly throughout the day and week, influenced by a multitude of factors, making it a less reliable indicator of consistent progress
The same analysis also notes that approximately 15% of users experienced vomiting after microdosing Tirzepatide, which highlights that attempting lower or unconventional dosing does not eliminate acute adverse effects and may introduce its own pattern of harms